Avella Specialty Pharmacy has been recognized by Inc. Magazine as one of the 5,000 fastest-growing companies in the United States. Read More »

Walgreens has been awarded the 2017 Infinity Arrow Award for Service and Take Back by the California Product Stewardship Council (CPSC) in recognition of the company’s Safe Medication Disposal program. Read More »

Amgen and Humana Inc. will collaborate on finding opportunities to improve health outcomes by analyzing the real-world health care experiences of Humana's 13 million members. Read More »

After a comprehensive review, CVS Pharmacy has retained Community Pharmacy Accreditation from industry benchmark organization Utilization Review Accreditation Commission. Read More »

Takeda Pharmaceuticals Co. Limited recently announced that it will collaborate with Stanford University to form the Stanford Alliance for Innovative Medicines (Stanford AIM) to transform novel Stanford research into next-generation treatments for diseases. Read More »

Ionis Pharmaceuticals Inc. will retain all rights to inotersen and IONIS-FB-LRx. Read More »

The international market for insulin delivery devices remains highly competitive with at least six major producers currently dominating the trade, according to Transparency Market Research, which predicts continued growth over the next eight years. Read More »

Regional Cancer Care Associates (RCCA) recently announced its attainment of accreditation by URAC, a leading nonprofit health care benchmark group, as a Specialty Pharmacy in Hackensack, New Jersey. Read More »

Health care investment firm Ampersand Capital Partners recently divested its former portfolio firm Roadrunner Pharmacy in a deal transferring Roadrunner to Vets First Choice after five years of supported growth in revenue and EBITDA. Read More »

Express Scripts, one of the largest pharmacy benefit managers (PBMs) in the country, has announced the expansion of a pilot program that limits opioid prescriptions to seven days without prior authorization. Read More »

The Center for Pharmacy Practice Accreditation has awarded PANTHERx Specialty Pharmacy a practice accreditation. Read More »

National Association of Specialty Pharmacy Executive Director Sheila Arquette recently responded to a report on direct and indirect remuneration fees commissioned by the Pharmaceutical Care Management Association. Read More »

Pharmacy Times, the leading media resource for pharmacists and the pharmacy industry, ranked highest in ad visibility and highest in readership in the 2017 Kantar Media Pharmacy Readership study. Read More »

Cumberland Pharmaceuticals, specializing in therapies for underserved populations, has begun shipping its Totect brand of dexrazoxane, for alleviating certain side effects of chemotherapy during cancer treatment, to U.S. wholesalers. Read More »

Animal health specialist firm Zoetis of Parsippany, New Jersey recently completed an approximately $85 million acquisition of Irish biologic therapeutics business Nexvet Biopharma PLC, with the deal expected to boost the company’s market share. Read More »

Spectrum Pharmacy Products, a top manufacturer and distributor of pharmaceutical chemicals and supplies, is partnering with the Independent Pharmacy Alliance (IPA), a retail pharmacy and trade group that represents thousands of pharmacies in the Northeastern U.S., PR Newswire reported. Read More »

Innovus Pharmaceuticals Inc., an expanding commercial-stage medication company that provides over-the-counter products for both men and women, will be filing a product licence application in Canada for its drug, Xyralid. Read More »

LabCorp, a provider of diagnostic solutions and breakthrough medicines, recently announced plans for its all-cash acquisition of international contract research firm Chiltern of England for approximately $1.2 billion, enhancing LabCorp’s portfolio and capabilities. Read More »

Phoenix-based Insys Therapeutics Inc. recently revealed that its new branded liquid formulation Syndros (dronabinol oral solution) is on the market to address side effects of AIDS and chemotherapy such as weight loss and related symptoms. Read More »

Los Angeles-based Puma Biotechnology Inc.’s FDA-approved Nerlynx (neratinib) tablets — a kinase inhibitor developed to treat breast cancer — will be circulated by Cary, North Carolina’s Biologics Inc. as per a limited distribution agreement between the companies. Read More »